Transforming Growth Factor‐α Induces the Differentiation of Sarcomatoid Cholangiocarcinoma Cells

por Enjoji, Munechika, Nakashima, Manabu, Nakamuta, Makoto, Nawata, Hajime
Publicado 2000

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake

por Yasutake, Kenichiro, Kohjima, Motoyuki, Nakashima, Manabu, Kotoh, Kazuhiro, Nakamuta, Makoto, Enjoji, Munechika
Publicado 2012

Analysis of Naturally Processed Human Histocompatibility Leukocyte Antigen Class I‐Bound Peptides from Hepatocellular Carcinoma Tissues in vivo

por Kobayashi, Hiroya, Sato, Keisuke, Miyokawa, Naoyuki, Kimura, Shoji, Nakashima, Manabu, Katagiri, Makoto
Publicado 1995

Sodium 4-phenylbutyrate suppresses the development of dextran sulfate sodium-induced colitis in mice

por ONO, KAZUHIKO, NIMURA, SATOSHI, NISHINAKAGAWA, TAKUYA, HIDESHIMA, YUKO, ENJYOJI, MUNECHIKA, NABESHIMA, KAZUKI, NAKASHIMA, MANABU
Publicado 2014

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

por Enjoji, Munechika, Machida, Kazuyuki, Kohjima, Motoyuki, Kato, Masaki, Kotoh, Kazuhiro, Matsunaga, Kazuhisa, Nakashima, Manabu, Nakamuta, Makoto
Publicado 2010